Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cem Gabay

Showing results (111-120 of 259) with videos related to

Pageof 26
Sort By:
Advances in Rheumatology (London, England)|December 6, 2019
Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumabKatie Tuckwell, Cem Gabay, Thierry Sornasse, et al.
Annals of the Rheumatic Diseases|October 25, 2018
Prolonged treatment with Tadekinig alfa in adult-onset Still's diseaseUta Kiltz, David Kiefer, Jürgen Braun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2008
The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14Sylvette Bas, Laurence Neff, Madeleine Vuillet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 2020
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1αPraxedis Martin, Gaby Palmer, Emiliana Rodriguez, et al.
The Journal of Biological Chemistry|April 10, 2022
Structural basis of human IL-18 sequestration by the decoy receptor IL-18 binding protein in inflammation and tumor immunitySam Detry, Julie Andries, Yehudi Bloch, et al.
Journal of Bacteriology|April 24, 2007
Molecular characterization and subcellular localization of macrophage infectivity potentiator, a Chlamydia trachomatis lipoproteinLaurence Neff, Sawsan Daher, Patrick Muzzin, et al.
Inflammatory Bowel Diseases|August 6, 2015
Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort StudySaskia Ditisheim, Nicolas Fournier, Pascal Juillerat, et al.
Joint Bone Spine|May 18, 2010
Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patientsAxel Finckh, Jean Dudler, Felix Wermelinger, et al.
Arthritis Research & Therapy|May 15, 2004
Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient miceEiva Bernotiene, Gaby Palmer, Dominique Talabot-Ayer, et al.
Annals of the Rheumatic Diseases|November 29, 2015
Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritisCem Gabay, Iain B McInnes, Arthur Kavanaugh, et al.
Pageof 26

Showing results (111-120 of 259) with videos related to

Sort By:
Pageof 26
Advances in Rheumatology (London, England)|December 6, 2019
Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumabKatie Tuckwell, Cem Gabay, Thierry Sornasse, et al.
Annals of the Rheumatic Diseases|October 25, 2018
Prolonged treatment with Tadekinig alfa in adult-onset Still's diseaseUta Kiltz, David Kiefer, Jürgen Braun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2008
The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14Sylvette Bas, Laurence Neff, Madeleine Vuillet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 2020
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1αPraxedis Martin, Gaby Palmer, Emiliana Rodriguez, et al.
The Journal of Biological Chemistry|April 10, 2022
Structural basis of human IL-18 sequestration by the decoy receptor IL-18 binding protein in inflammation and tumor immunitySam Detry, Julie Andries, Yehudi Bloch, et al.
Journal of Bacteriology|April 24, 2007
Molecular characterization and subcellular localization of macrophage infectivity potentiator, a Chlamydia trachomatis lipoproteinLaurence Neff, Sawsan Daher, Patrick Muzzin, et al.
Inflammatory Bowel Diseases|August 6, 2015
Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort StudySaskia Ditisheim, Nicolas Fournier, Pascal Juillerat, et al.
Joint Bone Spine|May 18, 2010
Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patientsAxel Finckh, Jean Dudler, Felix Wermelinger, et al.
Arthritis Research & Therapy|May 15, 2004
Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient miceEiva Bernotiene, Gaby Palmer, Dominique Talabot-Ayer, et al.
Annals of the Rheumatic Diseases|November 29, 2015
Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritisCem Gabay, Iain B McInnes, Arthur Kavanaugh, et al.
Pageof 26